1 Citation (Scopus)

Abstract

The pharmacologic treatment of attention-deficit/hyperactivity disorder (ADHD) generally involves the use of stimulant medications. Stimulants have been used for decades and have a long history of being safe and effective treatments. One significant limitation until recently has been the short time-action profile of this class of medications, requiring multiple doses to treat the child with ADHD throughout an entire day. Recent advances in drug-delivery systems have offered more options, leading to once-daily dosing for many patients taking stimulant therapy. For those patients who cannot tolerate or have limited response to stimulants, or simply prefer nonstimulant therapy, until recently few options have been available, however, a nonstimulant therapy is now available. This article will discuss newer formulations available for stimulant therapy, and findings from ongoing research of newly approved therapies and therapies currently in development.

Original languageEnglish (US)
Pages (from-to)S452-S457
JournalAdvanced Studies in Medicine
Volume3
Issue number5 C
StatePublished - May 1 2003

Fingerprint

Attention Deficit Disorder with Hyperactivity
Therapeutics
Drug Delivery Systems
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Newer agents and formulations for the treatment of ADHD. / Kratochvil, Christopher J.

In: Advanced Studies in Medicine, Vol. 3, No. 5 C, 01.05.2003, p. S452-S457.

Research output: Contribution to journalArticle

@article{e70eaac8a97b432ba4200b6484067757,
title = "Newer agents and formulations for the treatment of ADHD",
abstract = "The pharmacologic treatment of attention-deficit/hyperactivity disorder (ADHD) generally involves the use of stimulant medications. Stimulants have been used for decades and have a long history of being safe and effective treatments. One significant limitation until recently has been the short time-action profile of this class of medications, requiring multiple doses to treat the child with ADHD throughout an entire day. Recent advances in drug-delivery systems have offered more options, leading to once-daily dosing for many patients taking stimulant therapy. For those patients who cannot tolerate or have limited response to stimulants, or simply prefer nonstimulant therapy, until recently few options have been available, however, a nonstimulant therapy is now available. This article will discuss newer formulations available for stimulant therapy, and findings from ongoing research of newly approved therapies and therapies currently in development.",
author = "Kratochvil, {Christopher J}",
year = "2003",
month = "5",
day = "1",
language = "English (US)",
volume = "3",
pages = "S452--S457",
journal = "Advanced Studies in Medicine",
issn = "1530-3004",
publisher = "Galen Publishing LLC",
number = "5 C",

}

TY - JOUR

T1 - Newer agents and formulations for the treatment of ADHD

AU - Kratochvil, Christopher J

PY - 2003/5/1

Y1 - 2003/5/1

N2 - The pharmacologic treatment of attention-deficit/hyperactivity disorder (ADHD) generally involves the use of stimulant medications. Stimulants have been used for decades and have a long history of being safe and effective treatments. One significant limitation until recently has been the short time-action profile of this class of medications, requiring multiple doses to treat the child with ADHD throughout an entire day. Recent advances in drug-delivery systems have offered more options, leading to once-daily dosing for many patients taking stimulant therapy. For those patients who cannot tolerate or have limited response to stimulants, or simply prefer nonstimulant therapy, until recently few options have been available, however, a nonstimulant therapy is now available. This article will discuss newer formulations available for stimulant therapy, and findings from ongoing research of newly approved therapies and therapies currently in development.

AB - The pharmacologic treatment of attention-deficit/hyperactivity disorder (ADHD) generally involves the use of stimulant medications. Stimulants have been used for decades and have a long history of being safe and effective treatments. One significant limitation until recently has been the short time-action profile of this class of medications, requiring multiple doses to treat the child with ADHD throughout an entire day. Recent advances in drug-delivery systems have offered more options, leading to once-daily dosing for many patients taking stimulant therapy. For those patients who cannot tolerate or have limited response to stimulants, or simply prefer nonstimulant therapy, until recently few options have been available, however, a nonstimulant therapy is now available. This article will discuss newer formulations available for stimulant therapy, and findings from ongoing research of newly approved therapies and therapies currently in development.

UR - http://www.scopus.com/inward/record.url?scp=0038176166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038176166&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0038176166

VL - 3

SP - S452-S457

JO - Advanced Studies in Medicine

JF - Advanced Studies in Medicine

SN - 1530-3004

IS - 5 C

ER -